维普中文期刊产品整合服务
389篇 您的检索式:作者名="T Seto"
    题名 作者 年代 出处 被引量
1HER-2阳性胃癌对曲妥珠单抗为基础化疗的病理反应显示文摘以曲妥珠单抗为基础的化疗是目前治疗HER-2阳性晚期胃癌的标准方法,能有效延长晚期HER-2阳性胃癌患者总生存期和无进展生存率。由于手术标本较少,HER-2阳性胃癌曲妥珠单抗治疗后的组织病理学变化迄今尚未阐明。作者旨在描述HER-2阳性胃癌曲妥珠单抗治疗后胃癌组织反应及其与HER-2状态的相关性。Urabe M Ushiku T Seto Y Fukayama M 黄爱清 余英豪 2017临床与实验病理学杂志2017,33,5:5
2The inhibition of phenylhydroquinone-induced oxidative DNA cleavage by constituents of Moutan Cortex and Paeoniae Radix显示文摘Okubo T Nagai F Seto T 2000Biol Pharm Bull2000,23,:1
3Preparation of Mycoplasma hyopneumoniae antigen for the enzyme-linked immunosorbent assay显示文摘KAZAMA S YAGIHASHI T SETO K 1989Can J Vet Res1989,53,2:1
4Intrapleural hypotonic cispl- atin treatment for malignant pleural effusion in 80 patients with non - small - cell lung cancer:a multi - institutional phase II trial显示文摘T Seto S Ushijima H Yamamoto 2006Br J Cancer2006,95,6:1
5Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase 显示文摘Seto Y Iba T Abe K 2001Luminescence2001,16,4:1
6Hydrogen bonds显示文摘WHITESIDES G M MATHIAS J P SETO C T 1991Science1991,254,5036:1
7Laser synthesis and magnetic properties of monodispersed core-shell nanoparti- cles显示文摘Seto T Koga K Akinaga H 2004Appl Phys A: Mater Sci Process2004,79,46:1
8Ground-Glass Opacity on Thin-Section CT:Value in Differentiating Subtypes of Adenocarcinoma of the Lung显示文摘Kuriyama K Seto M Kasugai T 1999AJR1999,173,2:1
9Engineering of capillary-like structures in tissue constructs by electrochemical detachment of cells 显示文摘Seto Y Inaba R Okuyama T 2010Biomaterials2010,31,8:1
10Performance of a sur- face dielectric barrier discharge based reactor for destruction of naphthalene in an air stream显示文摘Abdelaziz A A Seto T Abdel-Salam M 2012Journal of Physics D: Applied Physics2012,45,11:1
11Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures显示文摘WHITESIDES G M MATHIAS J P SETO C T 1991Science1991,254,5036:1
12Intrapleural hypotonic eisplatin treatment for malignant pleural effusion in 80 patients with non - small - cell lung cancer: a multi - institutional phase II trial显示文摘Seto T Ushijima S Yamamoto H 2006Br J Cancer2006,95,6:1
13Phase Ⅱ trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer:Thoracic Oncology Research Group Study 0301显示文摘Onoda S Masuda N Seto T 2006J Clin Oncol2006,24,34:1
14Molecular self-assembly through hydrogen bonding: aggregation of five molecules to form a discrete supramolecular structure 显示文摘SETO C T MATHIAS J P WHITESIDE G M 1993J Am Chem Soc1993,115,:1
15Therapeutic approaches to muscular dystrophy显示文摘GOYENVALLE A SETO J T DAVIES K E 0,,:1
16Erlotinib alone or with Bevacizumab as first-line therapy in patients with advanced non- squamous non-small-cell lung cancer harbouring EGFR mutafions(JO25567): An open-label, randomised, muhicentre, phase 2 study显示文摘Seto T Kato T Nishio M 2014Lancet Oncol2014,15,11:1
17Construction and characterization of Escherichia coli disruptants defective in the yaeM gene显示文摘Kuzuyama T Takahashi S Seto H 1999Biosci Biotechnol Biochem1999,63,4:1
18Inhi- bition of miR - 15 protects against cardiac ischemic injury 显示文摘HULLINGER T G MONTGOMERY R L SETO A G 2012Circ Res2012,110,1:1
19Leukoplakia-associated multiple carcinomas in patients with togune carcinoma显示文摘Shibuya H Amagasa T Seto K 1986Caner1986,57,4:1
20Prognostic value of ex- pression of vascular endothelial growth factorand its flt-1 and KDR receptors in stage I non-small cell lung cancer显示文摘Seto T Higashiyama M Funai H 2006Lung Cancer2006,53,1:1
返回顶部 每页显示:
共20页 首页 上一页 第1页 下一页 末页 /20 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费